New Salipro & cancer research

The membrane protein SMO is an important drug target for cancer therapy. By combining Salipro® technology with cryoEM, the Yifan Cheng lab was able to visualise this class F GPCR protein in its apo state. Congratulations to the team for the structure of Salipro®-SMO!

Link to article

Previous
Previous

New research - Salipro & multidrug resistance

Next
Next

New study investigates bacterial multidrug resistance with Salipro®